A detailed history of Manufacturers Life Insurance Company, The transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 212,841 shares of RVMD stock, worth $9.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
212,841
Previous 212,368 0.22%
Holding current value
$9.21 Million
Previous $8.24 Million 17.0%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.92 - $47.94 $17,463 - $22,675
473 Added 0.22%
212,841 $9.64 Million
Q2 2024

Aug 14, 2024

BUY
$30.14 - $40.68 $401,404 - $541,776
13,318 Added 6.69%
212,368 $8.24 Million
Q1 2024

May 14, 2024

BUY
$26.56 - $33.55 $532,873 - $673,113
20,063 Added 11.21%
199,050 $6.42 Million
Q4 2023

Feb 13, 2024

BUY
$18.35 - $34.12 $430,325 - $800,148
23,451 Added 15.08%
178,987 $5.13 Million
Q3 2023

Nov 15, 2023

BUY
$25.17 - $35.05 $458,194 - $638,050
18,204 Added 13.26%
155,536 $4.31 Million
Q2 2023

Aug 11, 2023

BUY
$20.28 - $27.0 $891,062 - $1.19 Million
43,938 Added 47.05%
137,332 $3.67 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $871,504 - $1.26 Million
41,980 Added 44.95%
135,374 $2.93 Million
Q4 2022

Aug 11, 2023

BUY
$17.68 - $25.53 $84,793 - $122,441
4,796 Added 5.41%
93,394 $2.22 Million
Q4 2022

Feb 13, 2023

BUY
$17.68 - $25.53 $84,793 - $122,441
4,796 Added 5.41%
93,394 $2.22 Million
Q3 2022

Aug 11, 2023

BUY
$17.46 - $26.0 $82,568 - $122,954
4,729 Added 5.64%
88,598 $1.75 Million
Q3 2022

Nov 03, 2022

BUY
$17.46 - $26.0 $82,568 - $122,954
4,729 Added 5.64%
88,598 $1.74 Million
Q2 2022

Aug 11, 2023

BUY
$14.54 - $27.17 $8,680 - $16,220
597 Added 0.72%
83,869 $1.63 Million
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $8,680 - $16,220
597 Added 0.72%
83,869 $1.61 Million
Q1 2022

Aug 11, 2023

SELL
$17.31 - $26.4 $901,885 - $1.38 Million
-52,102 Reduced 38.49%
83,272 $2.12 Million
Q1 2022

May 20, 2022

BUY
$17.31 - $26.4 $907,528 - $1.38 Million
52,428 Added 169.98%
83,272 $2.13 Million
Q4 2021

Feb 16, 2022

BUY
$24.35 - $33.7 $9,837 - $13,614
404 Added 1.33%
30,844 $784,000
Q3 2021

Nov 12, 2021

SELL
$23.95 - $33.41 $59,587 - $83,124
-2,488 Reduced 7.56%
30,440 $837,000
Q2 2021

Aug 12, 2021

BUY
$29.0 - $47.44 $275,384 - $450,490
9,496 Added 40.53%
32,928 $1.05 Million
Q1 2021

May 03, 2021

BUY
$37.21 - $54.43 $36,242 - $53,014
974 Added 4.34%
23,432 $1.08 Million
Q4 2020

Feb 12, 2021

BUY
$30.19 - $45.49 $51,624 - $77,787
1,710 Added 8.24%
22,458 $889,000
Q3 2020

Nov 09, 2020

BUY
$22.61 - $34.8 $276,882 - $426,160
12,246 Added 144.04%
20,748 $722,000
Q2 2020

Aug 10, 2020

BUY
$19.65 - $39.34 $167,064 - $334,468
8,502 New
8,502 $260,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.